INTI (Inhibitor Therapeutics) Float Percentage Of Total Shares Outstanding: 54.07% (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Inhibitor Therapeutics Float Percentage Of Total Shares Outstanding?

Inhibitor Therapeutics INTI Float Percentage Of Total Shares Outstanding is 54.07% as of Aug. 01, 2026. The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Inhibitor Therapeutics's float shares is 93.31 Mil. Inhibitor Therapeutics's total shares outstanding is 172.57 Mil. Inhibitor Therapeutics's float percentage of total shares outstanding is 54.07%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Inhibitor Therapeutics's Insider Ownership is 7.13%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Inhibitor Therapeutics's Institutional Ownership is 0.00%.

Inhibitor Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Inhibitor Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=93.31/172.57
=54.07%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 54.07% mean?
Inhibitor Therapeutics (INTI) has a Float Percentage Of Total Shares Outstanding of 54.07% as of Aug. 01, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Inhibitor Therapeutics and its competitors.
Is Inhibitor Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Inhibitor Therapeutics' current Float Percentage Of Total Shares Outstanding is 54.07%.
How does Inhibitor Therapeutics' Float Percentage Of Total Shares Outstanding compare to TPST and AKTX?
Inhibitor Therapeutics' Float Percentage Of Total Shares Outstanding of 54.07% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Inhibitor Therapeutics and its competitors. Inhibitor Therapeutics's current Float Percentage Of Total Shares Outstanding is 54.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inhibitor Therapeutics stock overvalued right now?
Inhibitor Therapeutics (INTI) has a current Float Percentage Of Total Shares Outstanding of 54.07%. The current Float Percentage Of Total Shares Outstanding is 54.07%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Inhibitor Therapeutics (INTI), the current Float Percentage Of Total Shares Outstanding is 54.07% as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inhibitor Therapeutics Business Description

Address 3014 West Palmira Avenue, Suite 302, Tampa, FL, USA, 33629-7264
Inhibitor Therapeutics Inc is a pharmaceutical development company focused on developing and potentially commercializing therapeutics based on already approved active pharmaceutical ingredients, with a primary focus on basal cell carcinoma nevus syndrome (BCCNS), also known as Gorlin Syndrome. The Company develops therapeutics with patent-protected methods of use or delivery for certain cancers and non-cancerous proliferation disorders, and focuses on therapies for basal cell carcinoma (BCC) in the United States, utilizing itraconazole, an FDA-approved drug for fungal infections, with developed intellectual property and know-how related to the treatment of cancer patients using itraconazole.